Source:http://linkedlifedata.com/resource/pubmed/id/18255268
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-3-10
|
pubmed:abstractText |
Cyclooxygenases (COXs) are rate-limiting enzymes in the metabolic pathways in which arachidonic acid is converted to prostaglandins. COX-2 is the isoform induced at injury/inflammation sites and expressed constitutively in a few tissues, such as the central nervous system, and plays a role in neurodegenerative diseases associated with increased excitatory activity. However, the role of COX-2 and its main product, prostaglandin E(2) (PGE(2)), in the convulsive states is not fully established. In this study we showed that the selective COX-2 inhibitor, celecoxib (at the dose of 2mg/kg, but not at the doses of 0.2 or 20mg/kg, p.o.), protects against the seizures induced by pentylenetetrazol (PTZ, 60 mg/kg, i.p.). The role of PGE(2) in the convulsions induced by PTZ was further investigated by administering anti-PGE(2) antibodies (4 microg/2 microl, i.c.v.), and assessing electroencephalographic changes induced by PTZ (PTZ, 60 mg/kg, i.p.). Anti-PGE(2) antibodies attenuated PTZ-induced seizures in rats. In addition, combining PGE(2) (100 ng/2 microl, i.c.v.) with a subconvulsant dose of PTZ (20mg/kg, i.p.) caused seizures, further supporting a role for this prostaglandin in the convulsions induced by PTZ. Finally, we showed that the anticonvulsant action of celecoxib (2mg/kg, p.o.) was reversed by the intracerebroventricular administration of PGE(2) (10 ng/2 microl, i.c.v.). These data constitute strong converging pharmacological evidence supporting a facilitatory role for the COX-2/PGE(2) pathway in the seizures induced by PTZ. However, whether selective COX-2 inhibitors are safer anti-inflammatory drugs for epileptic patients than nonspecific inhibitors remains to be determined.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Dinoprostone,
http://linkedlifedata.com/resource/pubmed/chemical/Pentylenetetrazole,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides,
http://linkedlifedata.com/resource/pubmed/chemical/celecoxib
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0920-1211
|
pubmed:author |
pubmed-author:BohrerDeniseD,
pubmed-author:CastelliMarceloM,
pubmed-author:CavalheiroEsper AbraãoEA,
pubmed-author:FerreiraJulianoJ,
pubmed-author:FigheraMichele RechiaMR,
pubmed-author:FiorenzaNatália GindriNG,
pubmed-author:FurianAna FláviaAF,
pubmed-author:MachadoPabloP,
pubmed-author:MelloCarlos FernandoCF,
pubmed-author:OliveiraMauro SchneiderMS,
pubmed-author:RoyesLuiz Fernando FreireLF,
pubmed-author:VeigaMarleiM
|
pubmed:issnType |
Print
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
14-21
|
pubmed:meshHeading |
pubmed-meshheading:18255268-Analysis of Variance,
pubmed-meshheading:18255268-Animals,
pubmed-meshheading:18255268-Antibodies,
pubmed-meshheading:18255268-Cyclooxygenase 2,
pubmed-meshheading:18255268-Cyclooxygenase Inhibitors,
pubmed-meshheading:18255268-Dinoprostone,
pubmed-meshheading:18255268-Dose-Response Relationship, Drug,
pubmed-meshheading:18255268-Electroencephalography,
pubmed-meshheading:18255268-Male,
pubmed-meshheading:18255268-Pentylenetetrazole,
pubmed-meshheading:18255268-Pyrazoles,
pubmed-meshheading:18255268-Rats,
pubmed-meshheading:18255268-Rats, Wistar,
pubmed-meshheading:18255268-Seizures,
pubmed-meshheading:18255268-Signal Transduction,
pubmed-meshheading:18255268-Sulfonamides
|
pubmed:year |
2008
|
pubmed:articleTitle |
Cyclooxygenase-2/PGE2 pathway facilitates pentylenetetrazol-induced seizures.
|
pubmed:affiliation |
Departamento de Fisiologia e Farmacologia, Centro de Ciências da Saúde, Universidade Federal de Santa Maria, 97105-900 Santa Maria, RS, Brazil.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|